US House of Representatives passes bill to cap insulin price

One chamber of the United States Congress has passed a bill capping diabetes patients’ out-of-pocket insulin expenses.

Photo: George Frey/REUTERS / X02043

The US is one step closer to securing more affordable insulin for diabetes patients, as the House of Representatives has passed the Affordable Insulin Now Act, a bill that caps patients’ cost-sharing at USD 35 for a month’s supply of insulin.

The proposal now faces the Senate, which has previously been the stage for unsuccessful attempts to pass similar bills.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs